Priantti, J.N.; Vilbert, M.; de Moraes, F.C.A.; Madeira, T.; de Lima Santiago, E.M.; Leighl, N.B.; Cavalcante, L.; Karim, N.F.A.
Neurocognitive Adverse Events Related to Lorlatinib in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Cancers 2024, 16, 2611.
https://doi.org/10.3390/cancers16142611
AMA Style
Priantti JN, Vilbert M, de Moraes FCA, Madeira T, de Lima Santiago EM, Leighl NB, Cavalcante L, Karim NFA.
Neurocognitive Adverse Events Related to Lorlatinib in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Cancers. 2024; 16(14):2611.
https://doi.org/10.3390/cancers16142611
Chicago/Turabian Style
Priantti, Jonathan N., Maysa Vilbert, Francisco Cezar Aquino de Moraes, Thiago Madeira, Evair Moisés de Lima Santiago, Natasha B. Leighl, Ludimila Cavalcante, and Nagla F. Abdel Karim.
2024. "Neurocognitive Adverse Events Related to Lorlatinib in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis" Cancers 16, no. 14: 2611.
https://doi.org/10.3390/cancers16142611
APA Style
Priantti, J. N., Vilbert, M., de Moraes, F. C. A., Madeira, T., de Lima Santiago, E. M., Leighl, N. B., Cavalcante, L., & Karim, N. F. A.
(2024). Neurocognitive Adverse Events Related to Lorlatinib in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Cancers, 16(14), 2611.
https://doi.org/10.3390/cancers16142611